NO-induced vascular smooth muscle cell motility
NO诱导血管平滑肌细胞运动
基本信息
- 批准号:7541739
- 负责人:
- 金额:$ 35.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAGTR2 geneAbbreviationsAccountingAllelesAnalysis of VarianceAngiotensin IIAngiotensin ReceptorAntigensArginineAtherosclerosisAttenuatedBlood VesselsBromodeoxyuridineC-Type Natriuretic PeptideCell membraneChronicCultured CellsCyclic GMPCyclic GMP-Dependent Protein KinasesDNA biosynthesisEventExtracellular Signal Regulated KinasesGlycineHemagglutininHyperinsulinismInjuryInsulinInsulin ResistanceInternal Ribosome Entry SiteInvestigationLettersMediatingMetabolic syndromeMitogen-Activated Protein KinasesModelingMusN-acetylpenicillamineNitric OxideNon-Insulin-Dependent Diabetes MellitusObesityPH DomainPTPN11 genePathogenesisPathologyPhenylmethylsulfonyl FluoridePhosphatidylinositolsPlatelet-Derived Growth FactorPlayPolymerase Chain ReactionPrevalenceProtein Tyrosine PhosphataseProteinsPublicationsQuinoxalinesRattusRecruitment ActivityReportingResearch PersonnelRoleS-nitro-N-acetylpenicillamineSaralasinSmooth Muscle MyocytesSodium Dodecyl Sulfate-PAGETestingTyrosineVascular Diseasesadapter proteincell motilityenhanced green fluorescent proteinhuman NOS2A proteinhuman NOS3 proteininhibitor/antagonistinsightkinase inhibitorneointima formationprogramsprotein aminoacid sequencereceptorresearch studyresponsevascular smooth muscle cell proliferation
项目摘要
Nitric oxide (NO)is generally considered to play a protective role in blood vessels. However, others and we
have obtained evidence that this may not always be the case but the mechanisms underlying diverse
responses to NO are not known. The purpose of this proposal is to test an exciting new hypothesis on the
capacity of chronically elevated insulin levels to switch the role of nitric oxide from protective to deleterious
substance in blood vessels. We have found that the inhibitory effects of NO on both motility and proliferation
are abrogated in vascular smooth muscle cells chronically treated with insulin. These findings support a new
hypothesis on the role of insulin as a switcher of vascular smooth muscle cell phenotypic responses to NO.
Our preliminary results indicate that the motility-stimulatory effect of NO, uncovered by chronic insulin
treatment of cultured rat aortic smooth muscle cells, is associated with increased PI 3 kinase activity and
requires the functional availability of angiotensin II, of the adapter protein Gab1and the protein tyrosine
phosphatase SHP2. Studies by others have found that Gab1 can be recruited to the plasma membrane via
increased PIPS levels. However, the mechanistic linkage of chronic insulin treatment to Gab1 and SHP2
function has not been defined. Moreover, experiments to determine whether similar mechanisms may be
applicable to abrogation of the antiproliferative effect of NO by chronic insulin treatment have not been
performed. Finally, the pathophysiological significance of our results is unknown. We propose to implement
the following specific aims: Aim 1. To determine whether increased angiotensin II function is necessary
and/or sufficient to account for the effect of insulin on PI3K activity and NO-induced cell motility. Aim 2. To
determine whether chronic insulin treatment recruits Gab1 to the cell membrane and whether insulin-
independent recruitment of Gab1 or SHP2 to the cell membrane can mimic the motility-stimulatory effect of
NO uncovered by chronic insulin treatment. Aim 3: To uncover mechanisms that describe how
hyperinsulinemia attenuates the effect of NO as inhibitor of PDGF-induced DNA synthesis, in cultured rat
aortic smooth muscle cells. Aim 4. To determine whether expression of inducible nitric oxide synthase in
vascular injury enhances neointima formation in hyperinsulinemic mice, but has the opposite effect in
normoinsulinemic mice or in hyperinsulinemic mice treated with an AT1 receptor antagonist.
一氧化氮(NO)通常被认为在血管中起保护作用。然而,其他人和我们
已经获得了证据表明情况可能并不总是这样,但背后的机制不同
对NO的反应尚不清楚。这项提议的目的是检验一个令人兴奋的新假说
慢性升高的胰岛素水平将一氧化氮的作用从保护作用转换为有害作用的能力
血管中的物质。我们已经发现,NO对运动和增殖的抑制作用
在长期用胰岛素治疗的血管平滑肌细胞中被取消。这些发现支持一种新的
胰岛素作为血管平滑肌细胞对NO表型反应的开关作用的假说。
我们的初步结果表明,慢性胰岛素发现NO的运动刺激作用
对培养的大鼠主动脉平滑肌细胞的处理与PI-3K活性增加和
需要血管紧张素II、适配蛋白Gab1和酪氨酸蛋白的功能性可用性
磷酸酶SHP2。其他人的研究发现,GAB1可以通过
提高了点数水平。然而,慢性胰岛素治疗与GAB1和SHP2的机制联系
尚未定义函数。此外,确定类似机制的实验是否可能
适用于通过慢性胰岛素治疗消除NO的抗增殖作用
已执行。最后,我们的结果的病理生理学意义尚不清楚。我们建议实施
具体目标如下:目标1.确定是否有必要增加血管紧张素II的功能
和/或足以解释胰岛素对PI3K活性和NO诱导的细胞运动的影响。目标2.目标
确定慢性胰岛素治疗是否将GAB1招募到细胞膜,以及胰岛素是否-
GAB1或SHP2在细胞膜上的独立募集可以模拟
无慢性胰岛素治疗暴露。目标3:揭示描述如何
高胰岛素血症减弱NO抑制PDGF诱导的大鼠DNA合成的作用
主动脉平滑肌细胞。目的4.检测诱导型一氧化氮合酶(INOS)在卵巢癌中的表达
血管损伤促进高胰岛素血症小鼠的新生内膜形成,但对
正常胰岛素血症小鼠或用AT1受体拮抗剂治疗的高胰岛素血症小鼠。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suppression of PKG by PDGF or nitric oxide in differentiated aortic smooth muscle cells: obligatory role of protein tyrosine phosphatase 1B.
PDGF 或一氧化氮在分化的主动脉平滑肌细胞中抑制 PKG:蛋白酪氨酸磷酸酶 1B 的必然作用。
- DOI:10.1152/ajpheart.00225.2010
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Zhuang,Daming;Balani,Poonam;Pu,Qinghua;Thakran,Shalini;Hassid,Aviv
- 通讯作者:Hassid,Aviv
Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility.
蛋白激酶 G 和细胞质 Ca2 水平降低在 NO 诱导的大鼠主动脉平滑肌细胞运动抑制中的重要作用。
- DOI:10.1152/ajpheart.01031.2004
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Zhuang,Daming;Ceacareanu,Alice-Corina;Ceacareanu,Bogdan;Hassid,Aviv
- 通讯作者:Hassid,Aviv
Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.
长期胰岛素治疗通过抑制 PTP1B 的表达和功能,放大 PDGF 诱导的分化主动脉平滑肌细胞的运动。
- DOI:10.1152/ajpheart.01105.2007
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Zhuang,Daming;Pu,Qinghua;Ceacareanu,Bogdan;Chang,Yingzi;Dixit,Madhulika;Hassid,Aviv
- 通讯作者:Hassid,Aviv
Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.
与 NO 诱导分化的大鼠主动脉平滑肌细胞运动相关的机制。
- DOI:10.1152/ajpheart.00342.2010
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Pu,Qinghua;Zhuang,Daming;Thakran,Shalini;Hassid,Aviv
- 通讯作者:Hassid,Aviv
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AVIV HASSID其他文献
AVIV HASSID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AVIV HASSID', 18)}}的其他基金
Nitric Oxide-PTP Interactions In Aortic Smooth Muscle
主动脉平滑肌中一氧化氮-PTP 相互作用
- 批准号:
7064924 - 财政年份:2004
- 资助金额:
$ 35.44万 - 项目类别:
Nitric Oxide-PTP Interactions In Aortic Smooth Muscle
主动脉平滑肌中一氧化氮-PTP 相互作用
- 批准号:
6824708 - 财政年份:2004
- 资助金额:
$ 35.44万 - 项目类别:
Nitric Oxide-PTP Interactions In Aortic Smooth Muscle
主动脉平滑肌中一氧化氮-PTP 相互作用
- 批准号:
6899840 - 财政年份:2004
- 资助金额:
$ 35.44万 - 项目类别:
Nitric Oxide-Protein Tyrosine Phosphatase Interactions In Aortic Smooth Muscle
主动脉平滑肌中一氧化氮-蛋白酪氨酸磷酸酶的相互作用
- 批准号:
7234796 - 财政年份:2004
- 资助金额:
$ 35.44万 - 项目类别:
NO-induced vascular smooth muscle cell motility
NO诱导血管平滑肌细胞运动
- 批准号:
7033525 - 财政年份:2000
- 资助金额:
$ 35.44万 - 项目类别:
NO-induced vascular smooth muscle cell motility
NO诱导血管平滑肌细胞运动
- 批准号:
7333236 - 财政年份:2000
- 资助金额:
$ 35.44万 - 项目类别:
NO-induced vascular smooth muscle cell motility
NO诱导血管平滑肌细胞运动
- 批准号:
7163460 - 财政年份:2000
- 资助金额:
$ 35.44万 - 项目类别:














{{item.name}}会员




